VetSheet

Cromolyn Sodium

Cromolyn sodium

Ophthalmic Antiallergic / Mast Cell Stabilizertopical ophthalmicDogsCats

Also known as: Crolom ยท Sodium cromoglycate

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

one drop 2-6 times dailytopical ophthalmicยท q4-12h

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Dosing by species

๐ŸŒŽ NA โ€” North America๐ŸŒ EU โ€” Europe

Dogs

IndicationDoseRouteFrequencyDurationRegion
Relief of seasonal allergy / Allergic conjunctivitisone drop 2-6 times dailytopical ophthalmicq4-12hโ€”๐ŸŒŽ NA

Cats

IndicationDoseRouteFrequencyDurationRegion
Relief of seasonal allergy / Allergic conjunctivitisone drop 2-6 times dailytopical ophthalmicq4-12hโ€”๐ŸŒŽ NA

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Cromolyn sodium is a mast cell stabilizing agent used primarily in veterinary ophthalmology for the management of allergic conjunctivitis.

  • It lacks intrinsic vasoconstrictor, antihistaminic, cyclooxygenase (COX) inhibition, or other direct anti-inflammatory properties.
  • Because it prevents the release of inflammatory mediators rather than blocking their effects at the receptor level, it is most effective when used prophylactically or consistently over time.

โ€‹Clinical Pearl:โ€‹ Mast cell stabilizers are generally very safe for long-term use in companion animals suffering from seasonal allergic conjunctivitis, though they may require frequent daily dosing to maintain efficacy.

Mechanism of action

Cromolyn sodium acts as a mast cell stabilizer. Upon antigen recognition, it blocks the degranulation of sensitized mast cells โ†’ prevents the release of histamine and โ€‹slow-reacting substance of anaphylaxis (SRS-A)โ€‹ into the surrounding ocular tissues.

Safety & warnings

Adverse effects

  • Stinging sensation upon application (low percentage of patients)

Precautions

May cause a mild, transient stinging sensation upon application. Ensure the dropper tip does not touch the eye or surrounding structures to prevent contamination.

Monitoring

  • Resolution of clinical signs of allergic conjunctivitis (e.g., reduced hyperemia, chemosis, and pruritus)

Pharmacokinetics

Absorption

Minimal systemic absorption following topical ophthalmic application.

Overdose

Overdose via the topical ophthalmic route is highly unlikely to cause systemic toxicity. Excess drops will simply wash out of the conjunctival sac.

Available products

Formulations

  • 4% Ophthalmic Solution

Human-labeled

  • Cromolyn Sodium 4% Solution: 2.5, & 10 mL; Crolomยฎ (Bausch & Lomb)

Regulatory status

No regulatory data for: ๐Ÿ‡บ๐Ÿ‡ธ US ยท ๐Ÿ‡ช๐Ÿ‡บ EU ยท ๐Ÿ‡ฌ๐Ÿ‡ง UK ยท ๐Ÿ‡ญ๐Ÿ‡ฐ HK ยท ๐Ÿ‡น๐Ÿ‡ผ TW ยท ๐Ÿ‡ฏ๐Ÿ‡ต JP ยท ๐Ÿ‡ฐ๐Ÿ‡ท KR ยท ๐Ÿ‡ฆ๐Ÿ‡บ AU

Storage & stability

Store at room temperature away from moisture and direct sunlight. Keep the bottle tightly closed when not in use.

Client information

Administration Guide

  • Wash hands before and after applying the medication.
  • Apply the exact number of drops prescribed. Wait at least 5 minutes before applying any other eye medications.
  • Do not touch the dropper tip to your pet's eye, eyelids, or any other surface to keep the medication sterile.
  • Your pet may experience a brief, mild stinging sensation immediately after the drops are applied. If your pet rubs their eye excessively or the eye becomes more red, contact your veterinarian.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturerโ€™s current label.